Contractility assessment of axoCells atrial cardiomyocytes on the FLEXcyte 96 platform

Functional and pharmacological differences between the contractility of axoCells^TM iPSC-derived atrial and ventricular cardiomyocytes assessed on the FLEXcyte 96

In this application note we show that distinct pharmacological effects can be observed between axoCells^TM atrial and ventricular hiPSC-derived cardiomyocytes when using the FLEXcyte 96 platform to assess contractility.